About Jie Fan
Form D filings for Tiger Biotherapeutics in 2023 list Jie Fan as CEO and director.
Jie Fan first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Jie Fan in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Jie Fan works with at each company, as listed on that company's latest Form D.
Tiger Biotherapeutics Inc. · Form D, Apr 5, 2023
QZ
Quan Zhou
Director
BC
Bihua Chen
Director